NTCP modeling analysis of acute hematologic toxicity in whole pelvic radiation therapy for gynecologic malignancies – A dosimetric comparison of IMRT and spot-scanning proton therapy (SSPT)

Mell, 2006, Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy, Int J Radiat Oncol Biol Phys, 66, 1356, 10.1016/j.ijrobp.2006.03.018

Albuquerque, 2011, Radiation-related predictors of hematologic toxicity after concurrent chemoradiation for cervical cancer and implications for bone marrow-sparing pelvic IMRT, Int J Radiat Oncol Biol Phys, 79, 1043, 10.1016/j.ijrobp.2009.12.025

Mell, 2008, Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer, Int J Radiat Oncol Biol Phys, 71, 1504, 10.1016/j.ijrobp.2008.04.046

Brixey, 2002, Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies, Int J Radiat Oncol Biol Phys, 54, 1388, 10.1016/S0360-3016(02)03801-4

Knopf, 2013, In vivo proton range verification: a review, Phys Med Biol, 58, R131, 10.1088/0031-9155/58/15/R131

Shimizu, 2014, Preliminary analysis for integration of spot-scanning proton beam therapy and real-time imaging and gating, Phys Med, 30, 555, 10.1016/j.ejmp.2014.04.002

Dinges, 2015, Bone marrow sparing in intensity modulated proton therapy for cervical cancer: efficacy and robustness under range and setup uncertainties, Radiother Oncol, 115, 373, 10.1016/j.radonc.2015.05.005

Marnitz, 2015, Radiat Oncol, 10, 91, 10.1186/s13014-015-0402-z

Lomax, 2008, Intensity modulated proton therapy and its sensitivity to treatment uncertainties 1: the potential effects of calculational uncertainties, Phys Med Biol, 53, 1027, 10.1088/0031-9155/53/4/014

Lomax, 2008, Intensity modulated proton therapy and its sensitivity to treatment uncertainties 2: the potential effects of inter-fraction and inter-field motions, Phys Med Biol, 53, 1043, 10.1088/0031-9155/53/4/015

Bazan, 2012, Normal tissue complication probability modeling of acute hematologic toxicity in patients treated with intensity-modulated radiation therapy for squamous cell carcinoma of the anal canal, Int J Radiat Oncol Biol Phys, 84, 700, 10.1016/j.ijrobp.2011.12.072

Bazan, 2013, Impact of chemotherapy on normal tissue complication probability models of acute hematologic toxicity in patients receiving pelvic intensity modulated radiation therapy, Int J Radiat Oncol Biol Phys, 87, 983, 10.1016/j.ijrobp.2013.09.017

Small, 2008, Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer, Int J Radiat Oncol Biol Phys, 71, 428, 10.1016/j.ijrobp.2007.09.042

Gay, 2012, Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas, Int J Radiat Oncol Biol Phys, 83, e353, 10.1016/j.ijrobp.2012.01.023

Umezawa, 2013, Development of the compact proton beam therapy system dedicated to spot scanning with real-time tumor-tracking technology, AIP Conf Proc, 1525, 360, 10.1063/1.4802351

Zhu, 2011, Patient-specific quality assurance for prostate cancer patients receiving spot scanning proton therapy using single-field uniform dose, Int J Radiat Oncol Biol Phys, 81, 552, 10.1016/j.ijrobp.2010.11.071

Lin, 2015, Initial report of pencil beam scanning proton therapy for post hysterectomy patients with gynecologic cancer, Int J Radiat Oncol Biol Phys, 95, 181, 10.1016/j.ijrobp.2015.07.2205

Park, 2012, A beam-specific planning target volume (PTV) design for proton therapy to account for setup and range uncertainties, Int J Radiat Oncol Biol Phys, 82, e329, 10.1016/j.ijrobp.2011.05.011

Radiation Therapy Oncology Group (RTOG). 0921 <https://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?study=0921/>; [accessed 2015.11.11].

Feuvret, 2006, Conformity index: a review, Int J Radiat Oncol Biol Phys, 64, 333, 10.1016/j.ijrobp.2005.09.028

Sio, 2016, Spot-scanned pancreatic stereotactic body proton therapy: a dosimetric feasibility and robustness study, Phys Med, 32, 331, 10.1016/j.ejmp.2015.12.009

Lyman, 1985, Complication probability as assessed from dose-volume histograms, Radiat Res Suppl, 8, S13, 10.2307/3583506

Kutcher, 1989, Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method, Int J Radiat Oncol Biol Phys, 16, 1623, 10.1016/0360-3016(89)90972-3

Kutcher, 1991, Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations, Int J Radiat Oncol Biol Phys, 21, 137, 10.1016/0360-3016(91)90173-2

Burman, 1991, Fitting of normal tissue tolerance data to analytic function, Int J Radiat Oncol Biol Phys, 21, 123, 10.1016/0360-3016(91)90172-Z

Luxton, 2008, A new formula for normal tissue complication probability (NTCP) as a function of equivalent uniform dose (EUD), Phys Med Biol, 53, 23, 10.1088/0031-9155/53/1/002

Niemierko, 1999, A generalized concept of equivalent uniform dose (EUD), Med Phys, 26, 1100

Common Terminology Criteria for Adverse Events V4.0 (CTCAE). <http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm#ctc_40/>; 2009 [accessed 2015.09.16].

Yanazume, 2015, Potential proton beam therapy for recurrent endometrial cancer in the vagina, J Obstet Gynaecol Res, 41, 813, 10.1111/jog.12611

Dias, 2015, Scan path optimization with/without clustering for active beam delivery in charged particle therapy, Phys Med, 31, 130, 10.1016/j.ejmp.2015.01.001

Jakobi, 2015, Identification of patient benefit from proton therapy for advanced head and neck cancer patients based on individual and subgroup normal tissue complication probability analysis, Int J Radiat Oncol Biol Phys, 92, 1165, 10.1016/j.ijrobp.2015.04.031

Jakobi, 2015, Increase in tumor control and normal tissue complication probabilities in advanced head-and-neck cancer for dose-escalated intensity-modulated photon and proton therapy, Front Oncol, 5, 256, 10.3389/fonc.2015.00256

Jakobi, 2015, NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy, Acta Oncol, 54, 1658, 10.3109/0284186X.2015.1071920

Makishima, 2015, Comparison of adverse effects of proton and X-ray chemoradiotherapy for esophageal cancer using an adaptive dose-volume histogram analysis, J Radiat Res, 56, 568, 10.1093/jrr/rrv001

Toramatsu, 2013, What is the appropriate size criterion for proton radiotherapy for hepatocellular carcinoma? A dosimetric comparison of spot-scanning proton therapy versus intensity-modulated radiation therapy, Radiat Oncol, 8, 48, 10.1186/1748-717X-8-48

Liu, 2012, Robust optimization of intensity modulated proton therapy, Med Phys, 39, 1079, 10.1118/1.3679340

Blanco Kiely, 2016, Robust proton pencil beam scanning treatment planning for rectal cancer radiation therapy, Int J Radiat Oncol Biol Phys, 95, 208, 10.1016/j.ijrobp.2016.02.037